UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity

Science translational medicine, 2010-08, Vol.2 (44), p.44ra57

2010

Link zum Volltext

Verfügbarkeit prüfen

Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway

PLoS pathogens, 2014-04, Vol.10 (4), p.e1003989-e1003989

2014

Link zum Volltext

Verfügbarkeit prüfen

Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells

Nature immunology, 2005-05, Vol.6 (5), p.507-514

2005

Link zum Volltext

Verfügbarkeit prüfen

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

Blood, 2010-06, Vol.115 (22), p.4384-4392

2010

Link zum Volltext

Verfügbarkeit prüfen

Challenges and prospects of immunotherapy as cancer treatment

Biochimica et biophysica acta, 2007-09, Vol.1776 (1), p.108-123

2007

Link zum Volltext

Verfügbarkeit prüfen

Cancer immunotherapy based on killing of Salmonella-infected tumor cells

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (9), p.3920-3927

2005

Link zum Volltext

Verfügbarkeit prüfen

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity

PloS one, 2010-09, Vol.5 (9), p.e12670

2010

Link zum Volltext

Verfügbarkeit prüfen

Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway

Journal of Virology, 2011-10, Vol.85 (20), p.10814-10825

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer

Breast cancer research : BCR, 2018-06, Vol.20 (1), p.44-15, Article 44

2018

Link zum Volltext

Verfügbarkeit prüfen

Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope

PloS one, 2011-06, Vol.6 (6), p.e21214-e21214

2011

Link zum Volltext

Verfügbarkeit prüfen

Natural history of patients with advanced cholangiocarcinoma and FGFR2 gene fusions/rearrangements

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.391-391

2022

Link zum Volltext

Verfügbarkeit prüfen

Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4), p.876-886

2012

Link zum Volltext

Verfügbarkeit prüfen

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

Clinical cancer research, 2022-06, Vol.28 (11), p.2270-2277

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2206: Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2206-2206

2019

Link zum Volltext

Verfügbarkeit prüfen

PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib versus gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS4171-TPS4171

2022

Link zum Volltext

Verfügbarkeit prüfen

Selecting antigens for cancer vaccines: a cancer vaccine is streamlined by identifying a small set of potent immunogens in a tumor cDNA library

Nature biotechnology, 2012-04, Vol.30 (4), p.328

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2894: Neratinib effects significant changes in human brain endothelial cells, demonstrating that it may have a therapeutic use in cancers with brain metastasis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2894-2894

2018

Link zum Volltext

Verfügbarkeit prüfen

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis

The Journal of experimental medicine, 2009-05, Vol.206 (5), p.1103-1116

2009

Link zum Volltext

Verfügbarkeit prüfen

Selecting antigens for cancer vaccines

Nature biotechnology, 2012-04, Vol.30 (4), p.328-329

2012

Link zum Volltext

Verfügbarkeit prüfen

Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1

Blood, 2012-05, Vol.119 (22), p.5182-5190

2012

Link zum Volltext

Verfügbarkeit prüfen

Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease

European journal of immunology, 2008-07, Vol.38 (7), p.1937-1947

2008

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2940: Molecular tumor profiling identifies actionable targets in patients with cholangiocarcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2940-2940

2020

Link zum Volltext

Verfügbarkeit prüfen

Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2

The American journal of dermatopathology, 2016-03, Vol.38 (3), p.201-207

2016

Link zum Volltext

Verfügbarkeit prüfen

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

The Journal of experimental medicine, 2012-10, Vol.209 (11), p.2113-2126

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(56)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity

Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway

Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

Challenges and prospects of immunotherapy as cancer treatment

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

Cancer immunotherapy based on killing of Salmonella-infected tumor cells

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity

Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer

Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope

Natural history of patients with advanced cholangiocarcinoma and FGFR2 gene fusions/rearrangements

Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

Abstract 2206: Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors

PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib versus gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement

Selecting antigens for cancer vaccines: a cancer vaccine is streamlined by identifying a small set of potent immunogens in a tumor cDNA library

Abstract 2894: Neratinib effects significant changes in human brain endothelial cells, demonstrating that it may have a therapeutic use in cancers with brain metastasis

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis

Selecting antigens for cancer vaccines

Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1

Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease

Abstract 2940: Molecular tumor profiling identifies actionable targets in patients with cholangiocarcinoma

Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

Suchergebnisse filtern